Registration
Advertiser Disclosure

Medical Technology, Devices, and Healthcare by Stryker Corporation

297.6
6.8000
2.23 %
At close 10/21
USD
USD
NYSE
Daily range
293.10 Arrow from to Icon 303.66
Weekly range
286.66 Arrow from to Icon 305.03
Live Price Short-Term Long-Term Signals Earnings Dividends Price History News
Upcoming Q3 2026 financial results release: SYK resistance levels in focus
  • Sergey Shendetskyi
  • 05.10.2026
Upcoming Q3 2026 financial results release: SYK resistance levels in focus
Stryker (SYK) stock is trading at $283.75, up 2.99% on the session and near its daily high. The price remains above its short- and medium-term moving averages, ...
#Forecast
Stryker shares technical analysis: Approaching $319.52 support on continued pressure
  • Ashutosh Sureka
  • 20.08.2026
Stryker shares technical analysis: Approaching $319.52 support on continued pressure
Stryker (SYK) stock is trading at $327.74, marking a daily decrease of 3.6%. The price remains below its key moving averages, reflecting persistent downward momentum in ...
#Forecast
Stryker stock breaks $314.99 support after quarterly revenue misses consensus forecast
  • Ciaran Ryan
  • 31.07.2026
Stryker stock breaks $314.99 support after quarterly revenue misses consensus forecast
Stryker (SYK) stock is trading at $327.77, marking a daily decline of 5.83%. The share price currently sits below its key moving averages, reflecting ongoing weakness in ...
#Forecast
Stryker stock drops more than 8% after upbeat Q2 results met with broad selling pressure
  • Ezequiel Gomes
  • 31.07.2026
Stryker stock drops more than 8% after upbeat Q2 results met with broad selling pressure
Stryker Corporation (SYK) plunged 8.02% after reporting strong second-quarter earnings with raised full-year guidance and fresh M&A activity, with sellers pressing the stock despite the ...
#Forecast
Stryker stock rises 1.63 percent as StrykerEndo promotes urology technology update
  • Ciaran Ryan
  • 30.07.2026
Stryker stock rises 1.63 percent as StrykerEndo promotes urology technology update
Stryker shared urologist Dr. Michael Zell's perspective on the technologies, innovation and partnership supporting the next chapter of its urology portfolio.Stryker directed followers to further ...
Stryker stock gains 2.02 percent as StrykerEndo promotes fast repairs and trusted service
  • Hanna Syniavska
  • 28.07.2026
Stryker stock gains 2.02 percent as StrykerEndo promotes fast repairs and trusted service
Stryker introduced the ProCare Select Plan to service the F88 Flexible Ureteroscope with fast repairs and predictable pricing.The plan enables repairs in as fast as 24 hours. Stryker said this ...
Stryker stock gains 1.99 percent as StrykerEndo promotes ProCare Select rapid repairs plan
  • Emilio Ghigini
  • 28.07.2026
Stryker stock gains 1.99 percent as StrykerEndo promotes ProCare Select rapid repairs plan
Stryker introduced the ProCare Select Plan for fast repairs and predictable pricing on its F88 Flexible Ureteroscope.The plan offers service with repairs in as fast as 24 hours. Stryker says this ...
Stryker stock drops more than 3% after debut of handheld robotic knee replacement device
  • Sholanke Dele
  • 17.07.2026
Stryker stock drops more than 3% after debut of handheld robotic knee replacement device
Stryker Corporation (SYK) dropped 3.37% after the company launched its Mako Robotic Power System for total knee replacements, introducing new robotic technology to the market. This move ...
#Forecast
SYK slides over 5% as selling pressure intensifies before earnings and amid cybersecurity disruption
  • Emilio Ghigini
  • 14.07.2026
SYK slides over 5% as selling pressure intensifies before earnings and amid cybersecurity disruption
Stryker Corporation (SYK) fell 5.28% as investors positioned cautiously ahead of its upcoming second-quarter results and amid ongoing concerns following its recent cybersecurity disruption. The ...
#Forecast
Stryker launches urology camera with LaserShield technology while stock edges lower
  • Jose Antonio Gastelum
  • 02.07.2026
Stryker launches urology camera with LaserShield technology while stock edges lower
Stryker has introduced the 1788 4K Pendulum Urology Camera Head equipped with LaserShield technology.LaserShield is designed to mitigate laser interference during urologic procedures. The device ...
Stryker stock slides 4.76 percent as StrykerEndo debuts 4K Pendulum Urology Camera Head with LaserShield
  • Dmytro Kharkov
  • 01.07.2026
Stryker stock slides 4.76 percent as StrykerEndo debuts 4K Pendulum Urology Camera Head with LaserShield
Stryker has introduced the 1788 4K Pendulum Urology Camera Head with LaserShield technology.LaserShield is designed to mitigate laser interference during urologic procedures. The product is part ...
-5.22% for Stryker stock as removal from Russell growth indexes triggers selling
  • Parshwa Turakhiya
  • 01.07.2026
-5.22% for Stryker stock as removal from Russell growth indexes triggers selling
Stryker (SYK) stock is trading at $313.27, marking a decline of 5.22% for the day. The stock is positioned below its key moving averages, reflecting negative short-term ...
#Forecast
Court decision lifting Boston Scientific injunction drives Stryker stock up 3.19%
  • Jainam Mehta
  • 19.06.2026
Court decision lifting Boston Scientific injunction drives Stryker stock up 3.19%
Stryker Corporation (SYK) stock is trading at $310.75, up 3.19% for the day. The stock is currently positioned above its short- and medium-term moving averages, ...
#Forecast
Why is Stryker stock up today?
  • Sholanke Dele
  • 18.06.2026
Why is Stryker stock up today?
Stryker Corporation (SYK) is trading at $307.92, up 2.25% on the day and sitting just above its 20-day moving average of $306.98. While showing neutral short-term momentum, the price remains below ...
#Forecast
Who We Are
Business Solutions
For Users
TU News
Popular Sections
Disclosures
CONTACT US
Legal
We are in Social Media
© IAFT Ltd., 2010-2026 All rights to the website are owned by IAFT Ltd.,
Registration number - HE 336186
  • Risk disclosure:

    Information on the TradersUnion.com website is for informational purposes only and does not constitute any motive or suggestion to visitors to invest money. Moreover, we hereby warn you that trading on the Forex and CFD markets is always a high risk. According to the statistics, 75-89% of customers lose the funds invested and only 11-25% of traders earn a profit. Trading in futures and options carries substantial risk of loss and is not suitable for every investor.

    That is why you should only invest money that you are prepared — or can afford — to lose at such high risks. Tradersunion.com does not provide any financial services, including investment or financial advisory services. Also, the Traders Union is not a broker and does not get money for trading in the Forex or CFD markets. Our website only provides information on brokers and the markets and helps its users to select the best brokerage company based on detailed information and objective analysis of brokers.

  • Disclaimer:

    Traders Union (TradersUnion.com) shall not be liable for the consequences of trading decisions made by the Client and for the possible loss of his capital resulting from the use of this website and information published on it.

    Forex market, CFD and cryptocurrency trading involves high risks and is not suitable for everyone. Before investing money, you need to adequately assess the level of your expertise and be aware of the risks, particularly in the context of trading with leverage. The information on this website is not intended for distribution or use by any person in any country or jurisdiction, where such distribution or use would be in violation of the local law or regulation. Any payments by Traders Union (TradersUnion.com) to the users of our website shall be legally interpreted solely as an incentive on our part for the activity on the website in the form of a deduction of a part of the advertising income; they shall not be a subject of any claims of our users or our obligations, a subject of disputes, as well as cannot be considered in relation to the services provided to users by brokers, both in fact and in their completeness and volume. The administration of the website shall not be liable for the content of user comments and reviews about the companies and shall not verify whether the authors of the reviews are indeed real clients of a specific company. All reviews, both negative and positive are published on the website without verification of their reliability; only offensive reviews that call for violence or any kind of discrimination and also reviews published from one group of IP addresses are moderated and removed. The authors of the materials shall be fully liable for the accuracy, completeness and impartiality of any information in the articles and reviews, including in the context of their use or mention of any brand names or trademarks. All mentions of the names of companies and their brands in any materials on the website shall be made in the context of communication of socially important information to the people about their activities by independent journalists, who are the authors. All evaluations and indicators on the website express the subjective opinion of the authors of the reviews (articles) and shall not be viewed as accurate statements and be a subject of disputes and claims against Traders Union.

  • Disclosure of advertisers and revenues:

    All the services on the Tradersunion.com website are free for you to use. Our team spends thousands of hours per annum researching brokers and gathering information about them to help investors all over the world to choose reliable companies and to avoid fraudsters.

    Indeed, the curating, sourcing, and organization of this process requires substantial financial investment by Tradersunion.com, which the website earns in the form of advertising payments. There are two types of advertising services on the website — direct advertising or partner (broker) participation programs. However, no services purchased by our partners shall affect the recommendations on our website, or our opinions, or ratings. Our ratings are based on our objective rating criteria and methodology; and the results are always equally and fairly applied to each broker. The work of our content authors and research groups does not involve any interaction with our advertisers and they do not have access to data concerning the amount of advertising purchased. For over 10 years we consider our independence, absolute openness, and objectivity as our main priority. Please follow the links to each of our affiliated broker’s websites. This will help Tradersunion.com to continue to provide our services to you for free.

onepercentfortheplanet.org https://gdpr.eu/ GDPR World Association of News Publishers